Such result is consistent with previous studies that the Wnt/β-catenin signaling pathway modulate the expression of MGMT gene, while suppressing the Wnt signaling enhances the TMZ sensitivity in GBM [26, 27]. This evidence concerns the gene MGMT and glioblastoma.